In the new study, published December 1, 2020, in the open-access journal eLife, researchers from UC San Francisco showed the drug, ISRIB, produced rapid restoration of youthful cognitive abilities in aged mice, accompanied by a rejuvenation of brain and immune cells that could help explain improvements in brain function.